Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
The Journal of Dermatological Treatment|November 5, 2019
Failure rates and survival times of systemic and biologic therapies in treating psoriasis: a retrospective studyNishadh Sutaria, Shiu-Chung AuJournal of Drugs in Dermatology : JDD|July 10, 2014
A comparison of psoriasis drug failure rates and reasons for discontinuation in biologics vs conventional systemic therapiesAdriane A Levin, Alice B Gottlieb, Shiu-chung AuDermatology Online Journal|June 22, 2017
Klippel-Trenauney syndrome with axillary hyperhidrosisYeun Jina Lim, David Rosmarin, Giannoula Klement, et al.Arthritis Care & Research|December 17, 2013
Analysis of trial data for infliximab and golimumab: baseline C-reactive protein level and prediction of therapeutic response in patients with psoriatic arthritisShiu-Chung Au, Marigdalia K Ramirez-Fort, Alice B GottliebExpert Opinion on Drug Safety|November 15, 2011
Etanercept: efficacy and safety for approved indicationsTodd A Kerensky, Alice B Gottlieb, Shimrat Yaniv, et al.Journal of Drugs in Dermatology : JDD|August 13, 2015
Biologic and Conventional Systemic Therapies Show Similar Safety and Efficacy in Elderly and Adult Patients With Moderate to Severe PsoriasisCaren Garber, Natalia Plotnikova, Shiu-chung Au, et al.Journal of Drugs in Dermatology : JDD|August 30, 2013
Comparison of the efficacy of biologics versus conventional systemic therapies in the treatment of psoriasis at a comprehensive psoriasis care centerShiu-Chung Au, Abdulaziz Madani, Marwan Alhaddad, et al.Journal of Drugs in Dermatology : JDD|March 8, 2012
A phase 2, open-label, investigator-initiated study to evaluate the safety and efficacy of apremilast in subjects with recalcitrant allergic contact or atopic dermatitisEva M Volf, Shiu-Chung Au, Nicole Dumont, et al.Clinical and Experimental Rheumatology|October 17, 2013
Continuous versus intermittent therapy for moderate-to-severe psoriasisMarigdalia K Ramirez-Fort, Adriane A Levin, Shiu-Chung Au, et al.Current Problems in Dermatology|March 20, 2014
Management of cutaneous human papillomavirus infection: pharmacotherapiesMarigdalia K Ramírez-Fort, Shiu-Chung Au, Syed Ali Javed, et al.Pageof 3